Both in Pharmaceuticals
MacroGenics vs Spruce Biosciences
Over the past year MGNX returned +42.6% and SPRB returned −61.7%; their daily moves had a correlation of 0.18.
MGNX +42.6% SPRB −61.7%Growth of $1, one year, split-adjusted
| Metric | MGNX | SPRB |
|---|---|---|
| Price | $2.41 | $45.22 |
| Market cap | $153.5M | $130.0M |
| Today | +1.26% | −3.42% |
| 1 month | −33.1% | +1.0% |
| 6 months | −23.0% | −21.1% |
| Year to date | +49.7% | −48.1% |
| 1 year | +42.6% | −61.7% |
| Revenue growth (YoY) | +378.0% | — |
| Gross margin | 100.0% | — |
| Net margin | 59.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | $173.3M | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 113.9% | 63.9% |
| Short % of float | 8.2% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).